Literature DB >> 18343960

Molecular modeling and dynamics studies of cytidylate kinase from Mycobacterium tuberculosis H37Rv.

Rafael Andrade Caceres1, Luís Fernando Saraiva Macedo Timmers, Ana Luiza Vivan, Cristopher Zandoná Schneider, Luiz Augusto Basso, Walter Filgueira De Azevedo, Diogenes Santiago Santos.   

Abstract

Bacterial cytidylate kinase or cytidine monophosphate kinase (CMP kinase) catalyses the phosphoryl transfer from ATP to CMP and dCMP, resulting in the formation nucleoside diphosphates. In eukaryotes, CMP/UMP kinase catalyses the conversion of UMP and CMP to, respectively, UDP and CDP with high efficiency. This work describes for the first time a model of bacterial cytidylate kinase or cytidine monophosphate kinase (CMP kinase) from mycobacterium tuberculosis (MtCMPK). We modeled MtPCMPK in apo form and in complex with cytidine 5'-monophosphate (CMP) to try to determine the structural basis for specificity. Comparative analysis of the model of MtCMPK allowed identification of structural features responsible for ligand affinities. Analysis of the molecular dynamics simulations of these two systems indicates the structural features responsible for the stability of the structure, and may help in the identification of new inhibitors for this enzyme.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18343960     DOI: 10.1007/s00894-008-0291-2

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  30 in total

Review 1.  Binding energy, specificity, and enzymic catalysis: the circe effect.

Authors:  W P Jencks
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1975

2.  Further development and validation of empirical scoring functions for structure-based binding affinity prediction.

Authors:  Renxiao Wang; Luhua Lai; Shaomeng Wang
Journal:  J Comput Aided Mol Des       Date:  2002-01       Impact factor: 3.686

Review 3.  From magic bullets back to the magic mountain: the rise of extensively drug-resistant tuberculosis.

Authors:  Susan E Dorman; Richard E Chaisson
Journal:  Nat Med       Date:  2007-03       Impact factor: 53.440

4.  Structures of escherichia coli CMP kinase alone and in complex with CDP: a new fold of the nucleoside monophosphate binding domain and insights into cytosine nucleotide specificity.

Authors:  P Briozzo; B Golinelli-Pimpaneau; A M Gilles; J F Gaucher; S Burlacu-Miron; H Sakamoto; J Janin; O Bârzu
Journal:  Structure       Date:  1998-12-15       Impact factor: 5.006

5.  Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase.

Authors:  W F De Azevedo; H J Mueller-Dieckmann; U Schulze-Gahmen; P J Worland; E Sausville; S H Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

6.  Prediction of the three-dimensional structure of human interleukin-7 by homology modeling.

Authors:  R T Kroemer; S W Doughty; A J Robinson; W G Richards
Journal:  Protein Eng       Date:  1996-06

7.  Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.

Authors:  Ariel Pablos-Mendez; Deepthiman K Gowda; Thomas R Frieden
Journal:  Bull World Health Organ       Date:  2002       Impact factor: 9.408

8.  Solution structure and function of an essential CMP kinase of Streptococcus pneumoniae.

Authors:  Liping Yu; Jamey Mack; Philip J Hajduk; Steve J Kakavas; Anne Y C Saiki; Claude G Lerner; Edward T Olejniczak
Journal:  Protein Sci       Date:  2003-11       Impact factor: 6.725

9.  Derivation of rules for comparative protein modeling from a database of protein structure alignments.

Authors:  A Sali; J P Overington
Journal:  Protein Sci       Date:  1994-09       Impact factor: 6.725

10.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

View more
  4 in total

1.  Exploring the molecular basis for selective binding of Mycobacterium tuberculosis Asp kinase toward its natural substrates and feedback inhibitors: a docking and molecular dynamics study.

Authors:  M Chaitanya; B Babajan; C M Anuradha; M Naveen; C Rajasekhar; P Madhusudana; Chitta Suresh Kumar
Journal:  J Mol Model       Date:  2010-02-07       Impact factor: 1.810

2.  Structural studies of shikimate dehydrogenase from Bacillus anthracis complexed with cofactor NADP.

Authors:  Guy Barros Barcellos; Rafael Andrade Caceres; Walter Filgueira de Azevedo
Journal:  J Mol Model       Date:  2008-11-29       Impact factor: 1.810

3.  Resistance related metabolic pathways for drug target identification in Mycobacterium tuberculosis.

Authors:  Ruben Cloete; Ekow Oppon; Edwin Murungi; Wolf-Dieter Schubert; Alan Christoffels
Journal:  BMC Bioinformatics       Date:  2016-02-08       Impact factor: 3.169

4.  Insight from the structural molecular model of cytidylate kinase from Mycobacterium tuberculosis.

Authors:  Nitin Kumar Verma; Balwinder Singh
Journal:  Bioinformation       Date:  2013-07-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.